George A. Makar

faculty photo
Assistant Professor of Clinical Medicine
Medical Director of Liver Transplantation, University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-8559
BS (Pharmacy)
Drake University, Des Moines, IA, 1995.
University of Iowa College of Medicine, 2000.
University of Pennsylvania School of Medicine, 2009.
Permanent link

Description of Itmat Expertise

transplant outcomes

Selected Publications

Makar GA, Holmes JH, Yang YX. : Angiotensin-Converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk. J Natl Cancer Inst 2014.

Goldberg DS, Makar G, Bittermann T, French B. : Center variation in the use of nonstandardized model for end-stage liver disease exception points. Liver Transpl 2013.

Robert Weinrieb, Omair Abbasi, Marlee Madora, Alexandra Leto, Kevin Lynch, George Makar : A Matched Comparison Study of Medical and Psychiatric Complications in Methadone-Maintained Liver Transplant Recipients: Re-evaluation Nine Years Later Academy of Psychosomatic Medicine, 60th Annual Meeting. 2013 Notes: oral presentation.

Cantor JP, Makar GA, Reddy KR, Furth EE: Hepatic Injury in the Liver Allograft Biopsy Continues Despite Hepatitis C Viral Clearance with Interferon Treatment. United States and Canadian Academy of Pathology Annual Meeting 2012 2012 Notes: Poster Presentation.

McConnell RA, Kim S, Ahmad NA, Falk GW, Forde KA, Ginsberg GG, Jaffe DL, Makar GA, Long WB, Panganamamula KV, Kochman ML. : Poor Discriminatory Function for Endoscopic Skills on a Computer-Based Simulator. Gastrointest Endosc 76: 993-1002, 2012.

Bittermann T, Makar G, Goldberg D. : Exception point applications for 15 points for liver transplantation: An unintended consequence of the Share 15 policy. American Association of Study of Liver Disease Annual Meeting 2012 2012 Notes: Oral Presentation.

Bittermann T, Makar G, Goldberg D. : Exception point applications for 15 points: an unintended consequence of the share 15 policy. Liver Transpl 18:: 1302-9, 2012 Notes: Oral Presentation.

Goldberg D, Bittermann T, Makar G: Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant 12: 1603-9, 2012.

Mendizabal M, Reddy KR, Cassuto J, Olthoff KM, Faust TW, Makar GA, Rand EB, Shaked A, Abt PL. : Liver transplantation in patients with cystic fibrosis: Analysis of united network for organ sharing data. Liver Transpl 17: 243-50, 2011.

Tsai DE, Hagemann IS, Morrissette JJ, Daber R, Xu D, Schuster SJ, Bloom RD, Ahya VN, Jessup M, Makar GA, Chen S, Reshef R. : Allograft vs non-allograft posttransplant lymphoproliferative disorder, characterization of 2 distinct subtypes as defined by presentation, histology, and outcome: a case series of 165 patients. American Society of Clinical Oncology (ASCO) Annual Meeting 2011. 2011 Notes: Oral Presentation.

back to top
Last updated: 12/01/2014
The Trustees of the University of Pennsylvania